TecDara shows strong myeloma control, but early infection risk demands vigilant prophylaxis; safety improves after six months, supporting second-line use.
Luciano J. Costa, MD, PhD
Advertisement
Articles by Luciano J. Costa, MD, PhD
Advertisement
Latest Updated Articles
Tec-Dara Cuts Death Risk 78% Without Raising Fatal ToxicitySeptember 26th 2026
Advertisement
Advertisement
Trending on Pharmacy Times
1
Tirzepatide Linked to More Weight Loss Than Semaglutide 7.2 mg
2
September 2026 in Pain Management: 4 Updates on Treatment and Pharmacy Practice
3
Pharmacists Can Close CKD Medication Adherence Gaps, PHTI Says
4
Orforglipron Edges Oral Semaglutide 25 mg in T2D, Indirect Comparison Finds
5